Streetbeat News

Regulatory

INDA

The Reserve Bank of India has decided to keep its interest rate unchanged at 6.50%. This decision may affect the performance of India-focused ETFs, such as INDA.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 4:46 am

BTCUSD

ETHUSD

The US Treasury's Office of Foreign Assets Control (OFAC) has flagged a group of cryptocurrency wallets linked to the illegal fentanyl trade, primarily based in China. The flagged entities include five individuals and one company, Valerian Labs. The wallets received nearly $3.8 million in cryptocurrency across Bitcoin, Ethereum, and Tron networks. Senator Elizabeth Warren has proposed a bill to crack down on crypto funding crimes. Bitcoin's price is down 0.50% in the last 24 hours.

Portfolio Pulse from Mehab Qureshi

October 06, 2023 | 4:07 am

GDX

QQQ

TAN

TLT

UUP

The Bureau of Labor Statistics will release the September jobs report on Friday, which is expected to show a decline in non-farm payrolls from 187,000 in August to 170,000 in September. The report could influence the Federal Reserve's decision on interest rates. Five ETFs that could be impacted by the report are Invesco DB USD Index Bullish Fund (UUP), iShares 20+ Year Treasury Bond (TLT), Invesco QQQ Trust Series 1 (QQQ), Invesco Solar ETF (TAN), and VanEck Gold Miners ETF (GDX).

Portfolio Pulse from Piero Cingari

October 05, 2023 | 10:02 pm

AMLX

Amylyx Pharmaceuticals has provided an update on the Accès Compassionnel for its drug AMX0035 in France. The company did not disclose specific details in the news.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 9:28 pm

TSLA

The U.S. Securities and Exchange Commission (SEC) has filed a lawsuit against Tesla Inc's CEO, Elon Musk, seeking his testimony over his 2022 Twitter purchase. The SEC launched an investigation to determine if securities fraud was committed during Musk's Twitter takeover. Musk reportedly bought Twitter shares before taking it private in a $44 billion deal. The SEC has tried to meet with Musk multiple times, but he has refused, citing various reasons including harassment.

Portfolio Pulse from Adam Eckert

October 05, 2023 | 9:03 pm

SFE

Safeguard Scientifics' board has approved a plan to voluntarily terminate the registration of its common stock with the SEC and voluntarily delist from Nasdaq.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 9:01 pm

AORT

Artivion has announced the presentation of real-world data from a post-market study of On-X Aortic Heart Valve Replacement patients treated with low dose Warfarin. The data was presented at the 37th European Association for Cardio-Thoracic Surgery Annual Meeting.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 8:53 pm

CLRB

Cellectar Biosciences Inc has filed for a shelf of up to 34.5 million shares of common stock by selling stockholders, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 8:50 pm

REGN

Regeneron Pharmaceuticals expects its Q3 financial results to include an acquired In-Process Research and Development (IPR&D) charge of $100M on a pre-tax basis, according to a recent filing.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 8:27 pm

NAVB

The NYSE American has announced that it will suspend trading in Navidea Biopharmaceuticals (NAVB).

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 8:22 pm